Orthocell Ltd (ASX:OCC, OTC:ORHHF) will participate in the Canaccord Genuity 46th Annual Growth Conference in Boston from August 11–13, 2026. Chairman John Van Der Wielen and managing director Paul Anderson will meet with life sciences investors during the event. The regenerative medicine company has also released an investor presentation alongside the announcement. Conference attendees can request one-on-one meetings with Orthocell through their Canaccord Genuity (TSX:CF, LSE:CF) sales representative.
The Markets by Proactive
Go to Proactive UK
Proactive’s coverage of London’s small caps continues on .com